Plans for First COVID Vaccines | Reuter’s

Posted on by

Nationwide coronavirus deaths hit the highest number for a single day in six months.

Vaccination of Americans against the coronavirus will begin as early as mid-December. And, some 60 million to 70 million doses of COVID-19 vaccine could be available per month beginning in January, after the regulatory approval of products from Pfizer Inc (PFE) and Moderna Inc (MRNA), said Moncef Slaoui, a former GlaxoSmithKline executive who is overseeing the vaccine portion of the U.S. program.

A Food and Drug Administration panel of outside advisers will meet next week on December 10, 2020, to discuss whether to recommend emergency use authorization of the Pfizer vaccine, developed with BioNTech. Moderna’s (MRNA) vaccine candidate is expected to be reviewed a week later.

“Some 20 million people could be inoculated against COVID-19 by the end of 2020 and most Americans will have access to highly effective (near 95% efficacy) vaccines by mid-2021”, said the chief adviser of the President’s Operation Warp Speed program .

“Within 24 hours, maybe at most 36 to 48 hours, from the approval, the vaccine can be in people’s arms,” Slaoui said.

An estimated 21 million healthcare workers and 3 million residents of long-term care facilities are expected to be first in line to receive the vaccine, according to a recommendation voted on by a CDC panel of advisers

References:

  1. https://mobile.reuters.com/article/amp/idUSKBN28B5DH?__twitter_impression=true
  2. https://www.msn.com/en-au/lifestyle/wellbeing/us-plans-for-first-covid-vaccines-as-pandemic-deaths-surge-again/ar-BB1bwJf5
Advertisements